Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Twist Bioscience CorpTWST · Entity 3619 | See Remark | May 03, 2024 | May 07, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Twist Bioscience Corp
Report date May 03, 2024 · Filed May 07, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 345,188 |
Reported balance
After 2024-05-03 transaction · row 1
1 source rowRow 1 · 2024-05-03 · Sale · Disposed 798 · Balance 345,188 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 200 | $145.08 | $29,016.00 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 8 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455,698 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F9 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $145.01 to $145.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 400 | $144.11 | $57,643.00 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 7 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 455,898 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $143.75 to $144.69 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 300 | $143.18 | $42,954.00 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,298 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $142.60 to $143.53 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 500 | $142.06 | $71,031.00 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 456,598 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $141.56 to $142.44 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 700 | $140.86 | $98,602.98 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457,098 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $140.45 to $141.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 900 | $139.54 | $125,584.47 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 457,798 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $139.17 to $140.04 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 734 | $138.30 | $101,512.42 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 458,698 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $138.12 to $138.54 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:22 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,830 | $137.58 | $251,766.28 |
DisclosureSEC source: 0001214659-21-002318 · marketforms-51607.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,432 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $137.12 to $137.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| February 19, 2021 Filed Feb 23, 2021 23:49 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $150.81 | $101,796.75 |
DisclosureSEC source: 0001214659-21-002296 · marketforms-51551.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,262 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 200 | $199.99 | $39,997.00 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 14 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 461,937 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F13 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $199.96 to $200.01 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 803 | $199.24 | $159,987.95 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 13 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462,137 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F12 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $198.90 to $199.90 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,001 | $198.38 | $396,958.78 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 12 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 462,940 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F11 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $197.88 to $198.88 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,300 | $197.08 | $453,286.99 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 11 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 464,941 F10 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $196.80 to $197.74 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 800 | $196.10 | $156,880.48 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 10 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467,241 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F9 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $195.69 to $196.59 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 900 | $194.93 | $175,435.47 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 9 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,041 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $194.51 to $195.50 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 369 | $193.00 | $71,217.00 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 8 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 468,941 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 100 | $191.81 | $19,181.00 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 7 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,310 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 606 | $189.66 | $114,933.48 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,410 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $189.64 to $189.75 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,700 | $188.72 | $320,825.02 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,016 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $188.38 to $189.20 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,820 | $187.56 | $341,352.28 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471,716 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $187.14 to $187.98 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,000 | $186.39 | $186,385.00 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 473,536 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $185.87 to $186.87 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 25, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,500 | $185.45 | $278,176.05 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 474,536 F2 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $184.79 to $185.69 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 22, 2021 Filed Jan 26, 2021 22:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 210 | $190.64 | $40,034.40 |
DisclosureSEC source: 0001214659-21-000826 · marketforms-51255.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476,036 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 22:55 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 194 | $141.29 | $27,410.26 |
DisclosureSEC source: 0001214659-21-000152 · marketforms-50804.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476,246 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,166 | $139.24 | $162,348.01 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 13 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 476,440 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F14 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $139.03 to $139.47 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,900 | $138.14 | $262,473.79 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 12 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477,606 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F13 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $137.77 to $138.71 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,201 | $137.13 | $301,824.23 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 11 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 479,506 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F12 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $136.76 to $137.75 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,371 | $136.34 | $186,926.25 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 10 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 481,707 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F11 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $135.76 to $136.75 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 578 | $134.87 | $77,953.70 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 9 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,078 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F10 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $134.64 to $135.38 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,527 | $133.67 | $204,111.80 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 8 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,656 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F9 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $133.25 to $134.12 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,133 | $132.70 | $150,344.68 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 7 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,183 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $132.26 to $133.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,514 | $131.53 | $330,675.72 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 486,316 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $131.21 to $131.84 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 900 | $130.62 | $117,560.97 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,830 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $130.12 to $130.97 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,300 | $129.50 | $297,842.41 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 489,730 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $129.01 to $129.99 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,100 | $128.57 | $141,422.05 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,030 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $127.95 to $128.94 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,100 | $127.03 | $266,752.92 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,130 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $126.88 to $127.86 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 00:27 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,210 | $126.40 | $152,948.48 |
DisclosureSEC source: 0001214659-20-010517 · marketforms-50654.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,230 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $125.89 to $126.85 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| November 30, 2020 Filed Dec 2, 2020 21:25 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 2,790 | $113.65 | $317,083.50 |
DisclosureSEC source: 0001214659-20-010113 · marketforms-50366.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 496,440 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 28, 2020. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 22:53 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $115.56 | $78,003.00 |
DisclosureSEC source: 0001214659-20-009873 · marketforms-50158.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,230 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| October 24, 2020 Filed Oct 27, 2020 20:48 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 802 | $85.97 | $68,947.94 |
DisclosureSEC source: 0001214659-20-008873 · marketforms-49872.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,905 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| September 01, 2020 Filed Sep 4, 2020 00:37 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantCommon Stock | 7,790 | $0.00 | $0.00 |
DisclosureSEC source: 0001214659-20-007682 · marketforms-49588.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,707 F1 · shares: Represents a restricted stock unit award ("RSU") of which 1/16th of the total number of RSUs vest on each quarterly anniversary of October 1, 2020, for a total vesting period of 48 months, subject to the Reporting Person's continuous service through each vesting date. Read SEC document |
| September 01, 2020 Filed May 23, 2023 20:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | GrantEmployee Stock Option (right to buy) · Derivative | 23,355 | $0.00 Strike: $67.85 | $0.00 |
DisclosureSEC source: 0001214659-23-007734 · marketforms-61589.xml · derivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,355 Underlying: Common Stock · 23,355 shares Expires 2030-08-31 F2 · balance_after: Represents performance stock options granted to the reporting person on September 1, 2020, that vested and became exercisable on December 19, 2022 as a result of the reporting person having met the applicable performance criteria. Read SEC document |
| August 20, 2020 Filed Aug 24, 2020 21:39 UTC | Twist Bioscience Corp TWST · Entity 3619 | Tax withholdingCommon Stock | 675 | $67.28 | $45,414.00 |
DisclosureSEC source: 0001214659-20-007443 · marketforms-49490.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,917 F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e). Read SEC document |
| July 16, 2020 Filed Jul 17, 2020 22:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 530 | $54.28 | $28,769.73 |
DisclosureSEC source: 0001214659-20-006396 · marketforms-49291.xml · nonDerivative · entry 7 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 493,592 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F8 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $54.04 to $54.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 16, 2020 Filed Jul 17, 2020 22:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 5,539 | $53.45 | $296,039.61 |
DisclosureSEC source: 0001214659-20-006396 · marketforms-49291.xml · nonDerivative · entry 6 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 494,122 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F7 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $53.02 to $54.02 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 16, 2020 Filed Jul 17, 2020 22:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 4,931 | $52.62 | $259,473.16 |
DisclosureSEC source: 0001214659-20-006396 · marketforms-49291.xml · nonDerivative · entry 5 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 499,661 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F6 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $51.99 to $52.98 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 22:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,200 | $57.20 | $68,642.04 |
DisclosureSEC source: 0001214659-20-006396 · marketforms-49291.xml · nonDerivative · entry 4 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 504,592 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F5 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $56.89 to $57.50 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 22:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,492 | $56.29 | $83,990.95 |
DisclosureSEC source: 0001214659-20-006396 · marketforms-49291.xml · nonDerivative · entry 3 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 505,792 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F4 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $55.88 to $56.83 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 22:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 6,608 | $55.49 | $366,668.01 |
DisclosureSEC source: 0001214659-20-006396 · marketforms-49291.xml · nonDerivative · entry 2 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 507,284 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F3 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $54.87 to $55.87 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 22:10 UTC | Twist Bioscience Corp TWST · Entity 3619 | SaleCommon Stock | 1,700 | $54.35 | $92,393.47 |
DisclosureSEC source: 0001214659-20-006396 · marketforms-49291.xml · nonDerivative · entry 1 Banyai William · CIK 0001753670 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513,892 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 23, 2019. F2 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $53.85 to $54.79 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.